84 related articles for article (PubMed ID: 8158416)
1. Effects of pravastatin in dyslipidaemic patients with and without hypertension.
Tsukiyama H; Otsuka K
J Hypertens Suppl; 1993 Dec; 11(5):S346-7. PubMed ID: 8158416
[No Abstract] [Full Text] [Related]
2. The effectiveness and safety of low dose pravastatin in elderly hypertensive hypercholesterolemic subjects on antihypertensive therapy.
Chan P; Lee CB; Lin TS; Ko JT; Pan WH; Lee YS
Am J Hypertens; 1995 Nov; 8(11):1099-104. PubMed ID: 8554733
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
[TBL] [Abstract][Full Text] [Related]
4. Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men--a randomized, placebo-controlled study.
Mallon PW; Miller J; Kovacic JC; Kent-Hughes J; Norris R; Samaras K; Feneley MP; Cooper DA; Carr A
AIDS; 2006 Apr; 20(7):1003-10. PubMed ID: 16603852
[TBL] [Abstract][Full Text] [Related]
5. Early Improvements in insulin sensitivity and inflammatory markers are induced by pravastatin in nondiabetic subjects with hypercholesterolemia.
Lee WJ; Lee WL; Tang YJ; Liang KW; Chien YH; Tsou SS; Sheu WH
Clin Chim Acta; 2008 Apr; 390(1-2):49-55. PubMed ID: 18201563
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of pravastatin in combination with captopril in hypertensive patients.
O'Callaghan CJ; Krum H; Conway EL; Lam W; Skiba MA; Howes LG; Louis WJ
Med J Aust; 1995 Feb; 162(4):206-8. PubMed ID: 7877544
[TBL] [Abstract][Full Text] [Related]
7. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
Stender S; Schuster H; Barter P; Watkins C; Kallend D;
Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
[TBL] [Abstract][Full Text] [Related]
8. [Beneficial effects of statins and angiotensin converting enzyme inhibitors on aggregability of red blood cells in hypertensive patients].
Korbut RA; Guzik B; Adamek-Guzik T; Korbut R
Folia Med Cracov; 2006; 47(1-4):37-49. PubMed ID: 18038611
[TBL] [Abstract][Full Text] [Related]
9. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
Davidson MH; Testolin LM; Maki KC; von Duvillard S; Drennan KB
Arch Intern Med; 1997 Jun; 157(11):1186-92. PubMed ID: 9183229
[TBL] [Abstract][Full Text] [Related]
10. Effects of fish oil, nifedipine and their combination on blood pressure and lipids in primary hypertension.
Landmark K; Thaulow E; Hysing J; Mundal HH; Eritsland J; Hjermann I
J Hum Hypertens; 1993 Feb; 7(1):25-32. PubMed ID: 8450517
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of pravastatin once daily in primary moderate hypercholesterolemia: the Israeli experience.
Beigel Y; Brook G; Eisenberg S; Fainaru M; Harats D; Levy Y; Rubinstein A; Skurnik Y
Isr J Med Sci; 1993 May; 29(5):272-7. PubMed ID: 8314685
[TBL] [Abstract][Full Text] [Related]
12. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
Strony J; Hoffman R; Hanson M; Veltri E
Clin Ther; 2008 Dec; 30(12):2280-97. PubMed ID: 19167588
[TBL] [Abstract][Full Text] [Related]
13. Effects of atorvastatin and pravastatin on glucose tolerance, adipokine levels and inflammatory markers in hypercholesterolaemic patients.
Ando H; Sugimoto K; Yanagihara H; Tsuruoka S; Saito T; Takamura T; Kaneko S; Fujimura A
Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1012-7. PubMed ID: 18430053
[TBL] [Abstract][Full Text] [Related]
14. Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia.
Koter M; Franiak I; Broncel M; Chojnowska-Jezierska J
Can J Physiol Pharmacol; 2003 May; 81(5):485-92. PubMed ID: 12774855
[TBL] [Abstract][Full Text] [Related]
15. Marked decrease in serum HDL cholesterol levels by combined probucol-pravastatin treatment in hypercholesterolemic NIDDM patients.
Ikeda T
Diabetes Care; 1993 May; 16(5):849-50. PubMed ID: 8495635
[No Abstract] [Full Text] [Related]
16. Effect of pravastatin treatment on glucose, insulin, and lipoprotein metabolism in patients with hypercholesterolemia.
Sheu WH; Shieh SM; Shen DD; Fuh MM; Jeng CY; Chen YD; Reaven GM
Am Heart J; 1994 Feb; 127(2):331-6. PubMed ID: 8296701
[TBL] [Abstract][Full Text] [Related]
17. [Pravastatin multicenter clinical trial in patients with hypercholesterolemia and multiple risk factors].
Barrett e Pesquisadores AC
Arq Bras Cardiol; 1997 Jan; 68(1):65-71. PubMed ID: 9334463
[TBL] [Abstract][Full Text] [Related]
18. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
[TBL] [Abstract][Full Text] [Related]
19. Phytosterols dissolved in diacylglycerol oil reinforce the cholesterol-lowering effect of low-dose pravastatin treatment.
Takeshita M; Katsuragi Y; Kusuhara M; Higashi K; Miyajima E; Mizuno K; Mori K; Obata T; Ohmori R; Ohsuzu F; Onodera Y; Sano J; Sawada S; Tabata S; Tokimitsu I; Tomonobu K; Yamashita T; Yasukawa T; Yonemura A; Nakamura H
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):483-91. PubMed ID: 17964767
[TBL] [Abstract][Full Text] [Related]
20. [Effectiveness of and tolerance to pravastatin in the short-term treatment of primary hypercholesterolemia].
Marnini P; Bonfanti P; Piantanida E; Venco A
Clin Ter; 1994 Jan; 144(1):49-53. PubMed ID: 8168352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]